Bath & Body Works, Inc. (NYSE:BBWI) Receives Consensus Recommendation of “Hold” from Brokerages

Shares of Bath & Body Works, Inc. (NYSE:BBWI) have been given an average rating of “Hold” by the eighteen ratings firms that are covering the firm, Marketbeat Ratings reports. Thirteen investment analysts have rated the stock with a hold recommendation and five have given a buy recommendation to the company. The average 12 month target price among brokerages that have updated their coverage on the stock in the last year is $23.5333.

A number of research analysts recently issued reports on the stock. Raymond James Financial restated a “market perform” rating on shares of Bath & Body Works in a research report on Wednesday, November 12th. Wells Fargo & Company decreased their price objective on Bath & Body Works from $33.00 to $25.00 and set an “overweight” rating for the company in a report on Friday, November 21st. Deutsche Bank Aktiengesellschaft initiated coverage on Bath & Body Works in a report on Thursday, January 8th. They set a “hold” rating and a $21.00 target price on the stock. Jefferies Financial Group assumed coverage on Bath & Body Works in a report on Wednesday, January 14th. They issued a “hold” rating and a $24.00 price target for the company. Finally, Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Bath & Body Works in a research note on Wednesday, October 8th.

Bath & Body Works Stock Up 1.4%

Shares of NYSE BBWI opened at $22.57 on Friday. Bath & Body Works has a 52 week low of $14.27 and a 52 week high of $41.87. The business’s 50 day moving average price is $20.13 and its 200 day moving average price is $25.24. The firm has a market cap of $4.62 billion, a P/E ratio of 6.94, a P/E/G ratio of 0.81 and a beta of 1.51.

Bath & Body Works (NYSE:BBWI) last announced its quarterly earnings data on Thursday, November 20th. The company reported $0.35 EPS for the quarter, missing the consensus estimate of $0.40 by ($0.05). The business had revenue of $1.59 billion for the quarter, compared to analyst estimates of $1.64 billion. Bath & Body Works had a net margin of 9.50% and a negative return on equity of 47.35%. The business’s revenue was down 1.0% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.49 earnings per share. Bath & Body Works has set its FY 2025 guidance at 2.870- EPS and its Q4 2025 guidance at 1.700- EPS. As a group, research analysts expect that Bath & Body Works will post 3.3 earnings per share for the current year.

Bath & Body Works Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, December 5th. Shareholders of record on Friday, November 21st were issued a $0.20 dividend. The ex-dividend date of this dividend was Friday, November 21st. This represents a $0.80 dividend on an annualized basis and a yield of 3.5%. Bath & Body Works’s payout ratio is presently 24.62%.

Insider Activity

In other news, Director Lucy Brady bought 3,470 shares of the stock in a transaction dated Friday, November 21st. The shares were acquired at an average cost of $14.40 per share, with a total value of $49,968.00. Following the purchase, the director directly owned 17,482 shares in the company, valued at $251,740.80. The trade was a 24.76% increase in their position. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Steven E. Voskuil bought 20,000 shares of the company’s stock in a transaction dated Friday, November 21st. The shares were acquired at an average price of $15.04 per share, for a total transaction of $300,800.00. Following the completion of the transaction, the director directly owned 33,925 shares in the company, valued at approximately $510,232. This trade represents a 143.63% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. In the last ninety days, insiders have acquired 33,513 shares of company stock worth $500,442. 0.26% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

Several large investors have recently made changes to their positions in BBWI. JPMorgan Chase & Co. lifted its position in shares of Bath & Body Works by 11.5% during the 2nd quarter. JPMorgan Chase & Co. now owns 7,080,106 shares of the company’s stock valued at $212,120,000 after buying an additional 733,000 shares in the last quarter. Alliancebernstein L.P. raised its position in Bath & Body Works by 2.2% during the third quarter. Alliancebernstein L.P. now owns 5,861,444 shares of the company’s stock worth $150,991,000 after acquiring an additional 123,648 shares during the period. Cooper Creek Partners Management LLC raised its position in Bath & Body Works by 42.7% during the second quarter. Cooper Creek Partners Management LLC now owns 5,409,919 shares of the company’s stock worth $162,081,000 after acquiring an additional 1,619,276 shares during the period. American Century Companies Inc. lifted its holdings in Bath & Body Works by 2,204.1% during the third quarter. American Century Companies Inc. now owns 5,174,370 shares of the company’s stock valued at $133,292,000 after purchasing an additional 4,949,796 shares in the last quarter. Finally, AQR Capital Management LLC increased its stake in shares of Bath & Body Works by 17.1% during the third quarter. AQR Capital Management LLC now owns 4,921,968 shares of the company’s stock worth $126,790,000 after purchasing an additional 718,642 shares in the last quarter. 95.14% of the stock is owned by institutional investors and hedge funds.

More Bath & Body Works News

Here are the key news stories impacting Bath & Body Works this week:

• Positive Sentiment: Zacks Research upgraded BBWI from “strong sell” to “hold,” a change that can attract buyers given the stock’s low valuation metrics and recent decline. Zacks Research Upgrade
• Negative Sentiment: Levi & Korsinsky announced the filing of a securities class action on behalf of BBWI shareholders, signaling formal litigation alleging investor harm tied to disclosures across the class period. Deadlines for seeking lead plaintiff roles are being set. Levi & Korsinsky Filing
• Negative Sentiment: Rosen Law Firm and multiple national plaintiffs’ firms (Bragar Eagel & Squire, Pomerantz, Faruqi & Faruqi, Bernstein Liebhard, etc.) have issued notices encouraging investors to contact them and to file for lead‑plaintiff roles by March deadlines — a coordinated wave that increases the likelihood of consolidated litigation and legal costs. Rosen Law Firm Notice
• Negative Sentiment: Bleichmar Fonti & Auld and other firms highlight that the suits follow a sharp multi‑day stock drop (reported as ~24% in some notices), asserting potential securities‑law violations by the company and certain executives — these claims, if consolidated, could prolong uncertainty. BFA Law Notice
• Negative Sentiment: Several smaller notices (Gross Law Firm, DJS Law Group, Schall, Bronstein Gewirtz & Grossman, Kessler Topaz, etc.) repeat similar claims and deadlines — the volume of notices increases headline risk and could pressure the stock if investors fear regulatory or settlement exposure. Representative PR Notice

About Bath & Body Works

Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.

Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.